• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小世界中的复杂网络一瞥:肿瘤微环境。

A brief glimpse of a tangled web in a small world: Tumor microenvironment.

作者信息

Talaat Iman M, Kim Byoungkwon

机构信息

Clinical Sciences Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.

Department of Pathology, H.H. Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, United Arab Emirates.

出版信息

Front Med (Lausanne). 2022 Aug 15;9:1002715. doi: 10.3389/fmed.2022.1002715. eCollection 2022.

DOI:10.3389/fmed.2022.1002715
PMID:36045917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9421133/
Abstract

A tumor is a result of stepwise accumulation of genetic and epigenetic alterations. This notion has deepened the understanding of cancer biology and has introduced the era of targeted therapies. On the other hand, there have been a series of attempts of using the immune system to treat tumors, dating back to ancient history, to sporadic reports of inflamed tumors undergoing spontaneous regression. This was succeeded by modern immunotherapies and immune checkpoint inhibitors. The recent breakthrough has broadened the sight to other players within tumor tissue. Tumor microenvironment is a niche or a system orchestrating reciprocal and dynamic interaction of various types of cells including tumor cells and non-cellular components. The output of this complex communication dictates the functions of the constituent elements present within it. More complicated factors are biochemical and biophysical settings unique to TME. This mini review provides a brief guide on a range of factors to consider in the TME research.

摘要

肿瘤是基因和表观遗传改变逐步积累的结果。这一概念加深了对癌症生物学的理解,并开启了靶向治疗的时代。另一方面,利用免疫系统治疗肿瘤的尝试由来已久,可追溯到古代,也有关于发炎肿瘤自发消退的零星报道。现代免疫疗法和免疫检查点抑制剂继承了这一成果。最近的突破拓宽了人们对肿瘤组织中其他因素的视野。肿瘤微环境是一个生态位或系统,协调包括肿瘤细胞和非细胞成分在内的各种细胞之间相互的动态相互作用。这种复杂通讯的结果决定了其中所含组成元素的功能。更复杂的因素是肿瘤微环境特有的生化和生物物理环境。本综述简要介绍了肿瘤微环境研究中需要考虑的一系列因素。

相似文献

1
A brief glimpse of a tangled web in a small world: Tumor microenvironment.小世界中的复杂网络一瞥:肿瘤微环境。
Front Med (Lausanne). 2022 Aug 15;9:1002715. doi: 10.3389/fmed.2022.1002715. eCollection 2022.
2
Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.促甲状腺滤泡癌细胞间通讯中断可作为免疫治疗机会
Adv Exp Med Biol. 2021;1350:33-66. doi: 10.1007/978-3-030-83282-7_2.
3
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.调节性 T 细胞浸润肿瘤的机制:对创新免疫精准治疗的启示。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002591.
4
Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity.癌症基因组与肿瘤微环境:相互作用的串扰塑造肺癌的可塑性。
Elife. 2022 Sep 8;11:e79895. doi: 10.7554/eLife.79895.
5
Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy.自噬调控激活冷肿瘤微环境,改善癌症免疫治疗。
Front Immunol. 2022 Oct 10;13:1018903. doi: 10.3389/fimmu.2022.1018903. eCollection 2022.
6
Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.了解B细胞恶性肿瘤中的免疫-基质微环境以实现有效的免疫治疗。
Front Oncol. 2021 Mar 25;11:626818. doi: 10.3389/fonc.2021.626818. eCollection 2021.
7
Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition.通过 EZH2 抑制克服免疫检查点阻断耐药性。
Trends Immunol. 2020 Oct;41(10):948-963. doi: 10.1016/j.it.2020.08.010.
8
Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.免疫检查点抑制剂作为肿瘤相关成纤维细胞介导免疫抑制的调节剂:全面综述。
Front Immunol. 2022 Oct 5;13:996145. doi: 10.3389/fimmu.2022.996145. eCollection 2022.
9
Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies.重编程肿瘤微环境以提高癌症免疫疗法的疗效。
Med Oncol. 2022 Sep 29;39(12):239. doi: 10.1007/s12032-022-01842-5.
10
Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action.前列腺素 E 受体 4 拮抗剂在癌症免疫治疗中的作用机制。
Front Immunol. 2020 Mar 10;11:324. doi: 10.3389/fimmu.2020.00324. eCollection 2020.

引用本文的文献

1
Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment.克服肿瘤微环境中髓样细胞诱导的免疫抑制的策略。
Front Oncol. 2023 Apr 11;13:1116016. doi: 10.3389/fonc.2023.1116016. eCollection 2023.
2
Editorial: Complexity of tumor microenvironment: A major culprit in cancer development, volume II.社论:肿瘤微环境的复杂性:癌症发展的主要元凶,第二卷
Front Endocrinol (Lausanne). 2023 Jan 12;13:1126778. doi: 10.3389/fendo.2022.1126778. eCollection 2022.
3
Editorial: Complexity of tumor microenvironment: A major culprit in cancer development.社论:肿瘤微环境的复杂性:癌症发展的主要元凶
Front Endocrinol (Lausanne). 2022 Oct 20;13:1059885. doi: 10.3389/fendo.2022.1059885. eCollection 2022.

本文引用的文献

1
Immunological Classification of Tumor Types and Advances in Precision Combination Immunotherapy.肿瘤类型的免疫分类与精准联合免疫治疗进展
Front Immunol. 2022 Feb 28;13:790113. doi: 10.3389/fimmu.2022.790113. eCollection 2022.
2
The Biology and Function of Extracellular Vesicles in Cancer Development.细胞外囊泡在癌症发展中的生物学特性与功能
Front Cell Dev Biol. 2021 Nov 5;9:777441. doi: 10.3389/fcell.2021.777441. eCollection 2021.
3
Crosstalk Between the Tumor Microenvironment and Cancer Cells: A Promising Predictive Biomarker for Immune Checkpoint Inhibitors.肿瘤微环境与癌细胞之间的串扰:免疫检查点抑制剂的一种有前景的预测生物标志物。
Front Cell Dev Biol. 2021 Oct 7;9:738373. doi: 10.3389/fcell.2021.738373. eCollection 2021.
4
Transcriptional Profiling and Functional Analysis of N1/N2 Neutrophils Reveal an Immunomodulatory Effect of S100A9-Blockade on the Pro-Inflammatory N1 Subpopulation.转录谱分析和 N1/N2 中性粒细胞的功能分析揭示 S100A9 阻断对促炎 N1 亚群的免疫调节作用。
Front Immunol. 2021 Aug 10;12:708770. doi: 10.3389/fimmu.2021.708770. eCollection 2021.
5
Lactic acid in macrophage polarization: The significant role in inflammation and cancer.巨噬细胞极化中的乳酸:在炎症和癌症中的重要作用。
Int Rev Immunol. 2022;41(1):4-18. doi: 10.1080/08830185.2021.1955876. Epub 2021 Jul 25.
6
Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma.多态性可能预测转移性黑色素瘤患者对 PD-1 阻断治疗的反应。
Front Immunol. 2021 Jun 9;12:672521. doi: 10.3389/fimmu.2021.672521. eCollection 2021.
7
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.肿瘤微环境中与免疫抵抗和耐药性相关的方面。
Front Immunol. 2021 May 27;12:656364. doi: 10.3389/fimmu.2021.656364. eCollection 2021.
8
The Role of Extracellular Vesicles in the Development of a Cancer Stem Cell Microenvironment Niche and Potential Therapeutic Targets: A Systematic Review.细胞外囊泡在癌症干细胞微环境生态位发展中的作用及潜在治疗靶点:一项系统综述
Cancers (Basel). 2021 May 18;13(10):2435. doi: 10.3390/cancers13102435.
9
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.高肿瘤突变负担未能预测所有癌症类型的免疫检查点阻断反应。
Ann Oncol. 2021 May;32(5):661-672. doi: 10.1016/j.annonc.2021.02.006. Epub 2021 Mar 15.
10
Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.免疫检查点分子——遗传变异作为癌症风险的标志物。
Front Immunol. 2021 Jan 14;11:606721. doi: 10.3389/fimmu.2020.606721. eCollection 2020.